Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Anesthesiology & pain · Peking University Third Hospital · Beijing

Dr. Wu Zhangyi吴长毅

Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

WZ

Professional overview

Changyi Wu is a Chief Physician in the Department of Anesthesiology at Peking University Third Hospital. Research and clinical focus include mechanisms and prevention of acute lung injury.

SpecialtyAnesthesiology & pain
Clinical titleChief Physician
Academic roles—
DepartmentDepartment of Anesthesiology
HospitalPeking University Third Hospital
CityBeijing

Areas of focus

Acute lung injuryResearch and clinical focus includes mechanisms and prevention of acute lung injury.

Background

  • 2006Published on immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in an ovalbumin-induced asthma model (International Immunopharmacology).
  • 2006Published on cloning and expression of rat heme oxygenase-1 gene in Lactococcus lactis (Journal of Applied and Environmental Biology).
  • 2006Published on effects of oral administration of HO-1-expressing Lactococcus lactis on intestinal inflammation and bacterial translocation in hemorrhagic shock rats (Chinese Critical Care Medicine).
  • 2007Published on anesthesia management for gynecologic tumor surgery during pregnancy (Practical Journal of Obstetrics and Gynecology).
  • 2010Published on clinical observation of height-adjusted bupivacaine dosage for combined spinal-epidural anesthesia in elective cesarean delivery (Chinese Journal of New Drugs).
  • 2011Published on impact of bispectral index monitoring on intraoperative dreaming incidence in propofol-based general anesthesia (Chinese Journal of Clinical Pharmacology).
  • 2013Reported anesthesia management for implantation of cardiac resynchronization therapy device in a patient with dilated cardiomyopathy (Chinese Journal of Clinical Physicians, Electronic Edition).
  • 2014Published on effects of low-dose ketamine on postoperative visceral pain after laparoscopic cholecystectomy (Chinese Journal of New Drugs).
  • 2015Published on intranasal administration of recombinant Lactococcus lactis expressing heme oxygenase-1 reducing hyperoxia-induced lung inflammation in rat pups (Biotechnology Letters).
  • 2019Published on correlation between analgesia/nociception index and post-spinal hypotension in hysteroscopy (Chinese Journal of Minimally Invasive Surgery).
  • 2022Published on protective effects of docosahexaenoic acid against lipopolysaccharide-induced intestinal mucosal injury in septic mice (Zhonghua Journal of Hospital Infection).

Professional roles

  • Expert Appraiser, Beijing Medical Association
  • Standing Committee Member, Spine Minimally Invasive Expert Committee, Chinese Society of Traditional Chinese Medicine
  • Member, Perioperative Infection Control Society, Chinese Society of Cardiothoracic and Vascular Anesthesia
  • Standing Committee Member and Secretary-General, Perioperative Medicine Society, China International Exchange and Promotive Association for Medical and Health Care (CPAM)
  • Member, Basic Science Group, Anesthesiology Branch, Beijing Medical Association
  • Youth Editor, Anesthesia Safety and Quality Control

Frequently asked questions

What does Dr. Wu Zhangyi specialize in?

Mechanisms and prevention of acute lung injury.

Which hospital and department is Dr. Wu Zhangyi in?

Department of Anesthesiology at Peking University Third Hospital

Sources

Dr. Wu Zhangyi has not reviewed this page.